[1] Ninomiya H.Intracellular cholesterol transport by NPC1/NPC2: Mysteries of Niemann-Pick disease type C[J].Functional and Structural Biology on the Lipo-network, 2006, :1-15 [2]Maulik M, Thinakaran G, Kar S.Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking niemann-pick type C1 protein[J].PLoS One, 2013, 8(1):e54605- [3]Vance J E.Transfer of cholesterol by the NPC team[J].Cell Metabolism, 2010, 12(2):105-106 [4]Bu B, Li J, Davies P, et al.Deregulation of cdk5,hyperphosphorylation,and cytoskeletal pathology in the Niemann-Pick type C murine model[J].The Journal of Neuroscience, 2002, 22(15):6515-6525 [5]Patterson M C, Hendriksz C J, Walterfang M, et al.Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update[J].Molecular genetics and metabolism, 2012, 106(3):330-344 [6] Pressey S N, Smith D A, Wong A M, et al.Early glial activation,synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice[J].Neurobiology of Disease, 2012, 45(3):1086-1100 [7]Yan X, Yang F, Lukas J, et al.Hyperactive glial cells contribute to axonal pathologies in the spinal cord of Npc1 mutant mice[J].Glia, 2014, 62(7):1024-1040 [8]Attems J, Jellinger K A.Olfactory tau pathology in Alzheimer disease and mild cognitive impairment[J].Clinical Neuropathology, 2006, 25(6):265-271 [9]Saunders-Pullman R, Hagenah J, Dhawan V, et al.Gaucher disease ascertained through a Parkinson’s center: imaging andclinical characterization[J].Movement Disorders, 2010, 25(10):1364-1372 [10]Loftus S K, Morris J A, Carstea E D, et al.Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene[J].Science, 1997, 277(5323):232-235 [11] Djordjevic J, Jones-Gotman M, De Sousa K, et al.Olfaction in patients with mild cognitive impairment and Alzheimer's disease[J].Neurobiology of Aging, 2008, 29(5):693-706 [12]McNeill A, Duran R, Proukakis C, et al.Hyposmia and cognitive impairment in Gaucher disease patients and carriers[J].Movement Disorders, 2012, 27(4):526-532 [13]Liao G, Yao Y, Liu J, et al.Cholesterol accumulation isassociated with lysosomal dysfunction and autophagic stress in Npc1-- mouse brain[J].The American Journal of Pathology, 2007, 171(3):962-975 [14]Sarna J R, Larouche M, Marzban H, et al.Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease[J].The Journal of Comparative Neurology, 2003, 456(3):279-291 [15]Bi X, Liao G.Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion[J].Autophagy, 2007, 3(6):646-648 [16]Kodam A, Maulik M, Peake K, et al.Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains[J].Glia, 2010, 58(11):1267-1281 [17]Yan X, Lukas J, Witt M, et al.Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse[J].Metabolic Brain Disease, 2011, 26(4):299-306 [18]Takikita S, Fukuda T, Mohri I, et al.Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse[J].Journal of Neuropathology and Experimental Neurology, 2004, 63(6):660-673 [19]Wang P Y, Weng J, Anderson R G.OSBP is a cholesterol-regulated scaffolding protein in control of ERK 12 activation[J].Science, 2005, 307(5714):1472-1476 [20]Fünfschilling U, Jockusch WJ, Sivakumar N, et al.Critical time window of neuronal cholesterol synthesis during neurite outgrowth[J].The Journal of Neuroscience, 2012, 32(22):7632-7645 [21]Hallows J L, Iosif R E, Biasell R D, et al.p35p25 is not essential for tau and cytoskeletal pathology or neuronal loss in Niemann-Pick type C disease[J].The Journal of Neuroscience, 2006, 26(10):2738-2744 [22]Cotter L, Oz?elik M, Jacob C, et al.Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination[J].Science, 2010, 328(5984):1415-1418 [23]Lee Y, Morrison B M, Li Y, et al.Oligodendroglia metabolically support axons and contribute to neurodegeneration[J].Nature, 2012, 487(7408):443-448